Project Grant R21DA062066
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$193K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This $399,536 Project Grant was awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to design, synthesize, and test non-opioid drug candidates that can help combat the national opioid crisis, with a focus on reversing the effects of synthetic opioids like fentanyl. The key goals are to: 1) Develop and characterize chemical lead compounds and control...
This $1,997,979 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to identify the genetic mechanisms underlying fentanyl addiction and incentive sensitization in mice. The overarching goal is to use the Collaborative Cross mouse panel, advanced behavioral assays, and multi-omics approaches to dissect the shared genetic drivers of fentanyl addiction, cocaine addiction, and incentive...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $184,706 to the University of North Carolina at Chapel Hill (UNC-CH) to investigate the impact of fentanyl consumption on noradrenergic plasticity in the basolateral amygdala. The research aims to understand how fentanyl alters brain circuits and neurotransmitters that regulate addiction-like behaviors and negative affect, with a focus on...
The University of Mississippi Medical Center (UMMC) was awarded a $1,509,492 project grant from the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to investigate the effects of fentanyl use during pregnancy on maternal health, placental function, and offspring development. Over the 3-year project period from August 1, 2023 to July 31, 2026, UMMC will conduct comprehensive assessments on pregnant female rats self-administering...
This $400,294 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of the serotonin 5-HT2A receptor in modulating the reinforcing value of the synthetic opioid fentanyl. The research aims to elucidate how adverse childhood experiences and chronic stress alter the rewarding aspects of fentanyl, with the goal of identifying a novel, non-opioid receptor target to control...
This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the interactions between the opioid fentanyl, non-opioid receptor mechanisms, and HIV/AIDS in the striatum region of the brain. The $3,904,555 award, which began on June 15, 2024 and will run through March 31, 2029, will identify the specific opioid, adrenergic, and other receptor mechanisms by which fentanyl and...
This $2,267,819 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Abuse and Addiction Research Programs) will fund research by the University of Washington to characterize extracellular vesicle (EV) profiles in healthy pregnancies and those complicated by opioid use disorder. The goal is to identify biomarkers in placental EVs and fetal brain/central nervous system EVs that could predict an infant's risk of developing neonatal opioid withdrawal syndrome (NOWS) and...
The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on investigating the effects of early-life cannabinoid exposure on the development of the prefrontal cortex and cognitive behaviors in mice. The total funding amount is $1,433,155, with the award period running from June 1, 2024 to March 31, 2029. The key objectives of this research project are to: 1) reveal the spatial and...
The National Institute on Drug Abuse (NIDA) awarded Magee-Womens Research Institute and Foundation a $3,092,159 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to conduct a multimodal analysis of gestational health and placental injury in opioid-affected pregnancies. The goal is to investigate the direct impact of illicit and prescription opioids on placental development, differentiation, and function, focusing on the critical syncytiotrophoblast and...